Cancer Biology

965 Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification

964 An oncolytic herpesvirus expressing E-cadherin improves survival in mouse models of glioblastoma.

963 Central body fatness is a stronger predictor of cancer risk than overall body size.

962 Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti–PD-1 for tumor abrogation.

961 Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody.

960 IL-15 is a component of the inflammatory milieu in the tumor microenvironment promoting antitumor responses.

959 Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin.

958 A large network of bacterial proteins promotes endogenous DNA damage and mutations when upregulated, acting like protein carcinogens, and has human homologs that form a cancer predictive network.

957 Actively personalized vaccination trial for newly diagnosed glioblastoma.

956 Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial.

955 De novo design of potent and selective mimics of IL-2 and IL-15.

954 Deletion of the A-to-I double-stranded RNA-editing enzyme ADAR1 sensitizes tumour cells to immunotherapy.

953 Organoid Modeling of the Tumor Immune Microenvironment.

952 Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture.

951 Altered ubiquitination of RAS GTPases is implicated in cancer drug resistance.

950 Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma.

949 Single-cell multiomics sequencing and analyses of human colorectal cancer.

948 Mannose impairs tumour growth and enhances chemotherapy.

947 Cancer-associated mutations are surprisingly common in normal esophageal epithelium from human donors.

946 Human-like hyperplastic prostate with low ZIP1 induced solely by Zn deficiency in rats.

Free Images for Presentation: sunipix SUNIPIX